Nilvadipine
From Self-sufficiency
| File:Nilvapidine.png | |
| Systematic (IUPAC) name | |
|---|---|
|
5-isopropyl 3-methyl 2-cyano-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | |
| Identifiers | |
| ATC code | C08CA10 (WHO) |
| PubChem | CID 4494 |
| Chemical data | |
| Formula | C19H19N3O6 |
| Molar mass | 385.370 g/mol[[Script error: No such module "String".]] |
Nilvadipine is a calcium channel blocker (CCB) for the treatment of hypertension and chronic major cerebral artery occlusion.
Pathohistochemical studies have revealed that the volume of the infarction in the middle cerebral artery occlusion model could be decreased by nilvadipine.
Currently, nilvadipine is tested in clinical trial as a possible treatment for Alzheimer's Disease in Ireland by the Roskamp Institute, Florida, USA and Trinity College, Ireland. [1]
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Calcium channel blockers
- Pyridines
- Nitriles
- Nitro compounds
- Carboxylate esters
- Cardiovascular system drug stubs
- 2Fix
